03 January 2025
: Case report 
Successful Treatment of a Patient Presenting with Simultaneous Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma: A Case Report
Unusual setting of medical care, Rare coexistence of disease or pathology
Jungmin Lee EF 1, Man Hoon Han BCDF 2, Dong Won Baek ADEF 1*DOI: 10.12659/AJCR.945435
Am J Case Rep 2025; 26:e945435
Table 5. Identified variants in the peripheral blood and bone marrow.
| Sample | Gene | DNA change | AA change | Read depth (X) | VAF (%) | Classification |
|---|---|---|---|---|---|---|
| Peripheral blood | ABL1 | c.287A>G | p.N96S | 632 | 46.8 | Tier III |
| ABL1 | c.2626A>G | p.R876G | 619 | 45.4 | Tier III | |
| FGFR1 | c.304G>A | p.V102I | 558 | 50.0 | Tier III | |
| Bone marrow | ABL1 | c.287A>G | p.N96S | 632 | 49.5 | Tier III |
| ABL1 | c.2626A>G | p.R876G | 619 | 50.7 | Tier III | |
| FGFR1 | c.304G>A | p.V102I | 558 | 49.1 | Tier III | |
| AA – amino acid; VAF – variant allele frequency. | ||||||